Inventurus Knowledge Solutions Limited — PPTs, 05-08-2026: Investor Presentation

Inventurus Knowledge Solutions delivered a strong Q1 FY27. Revenue from Operations hit 893.6 Cr, up 20.7% YoY (12% in USD). EBITDA grew 24% YoY to 294.9 Cr, with Net Profit (PAT) jumping 27.8% YoY to 193.7 Cr. Adjusted PAT also rose 28% YoY to 215.3 Cr, translating to an EPS of ₹11.6, up 27.5% YoY. The company generated robust cash flow.

Strategically, IKS Health focuses on expanding its healthcare enablement platform by integrating proprietary AI models and API-driven "System of Action" into large medical groups and rural health systems. Growth drivers include cross-selling to existing clients and boosting platform sales to mid-size groups, aiming for optimized margins via operational transformation.

Recent wins include a partnership with a premier California health system for clinical data migration and expanded RCM collaborations with existing clients like Advocate Health and StrideCare. The company also secured a US Patent for its AI-driven patient engagement engine.

Looking ahead, IKS Health aims for sustained EBITDA expansion without significant equity dilution, targeting an EBITDA of 3,000 Cr by FY30.